Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients
PurposesTo explore the value of metagenomic next-generation sequencing (mNGS) in diagnosing pneumocystis jiroveciipneumonia (PJP) in the immunocompromised patients.MethodsData of 122 patients with PJP in an immunosuppressed state and 67 non-PJP patients were collected. The diagnostic efficacy of mNG...
Main Authors: | Dongsheng Wang, Shihua Fang, Xiaowen Hu, Qixia Xu, Xinmin Chu, Xiaodong Mei, Wang Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.913405/full |
Similar Items
-
The diagnostic value of metagenomic next-generation sequencing for identifying Pneumocystis jirovecii infection in non-HIV immunocompromised patients
by: Mengyi Zhao, et al.
Published: (2022-10-01) -
Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing
by: Liping Huang, et al.
Published: (2023-02-01) -
Metagenomic next‐generation sequencing for pneumocystis jirovecii pneumonia in patients with connective tissue disease
by: Jianwen Liu, et al.
Published: (2023-06-01) -
Study on mNGS Technique in Diagnosing Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients
by: Li S, et al.
Published: (2024-04-01) -
The Clinical Value of Metagenomic Next-Generation Sequencing in Pneumocystis jirovecii Pneumonia
by: Huang MQ, et al.
Published: (2024-01-01)